Performance
to relieve your
OA knee pain

About EUFLEXXA

The OA knee pain relief
you need right where
you need it

Hyaluronic acid (HA) is
a substance already in
the fluid of your knee.
It helps lubricate the
joint. When you have
osteoarthritis (OA),
the HA in your joint
becomes thinner and less effective.

EUFLEXXA is a hyaluronic acid that’s
injected directly into the knee by your
healthcare provider. It replenishes some
of the HA in your knee, helping with the
lubrication and shock absorption you need
within the knee joint.

It’s created in a controlled
environment—with a precise, multistep
cleansing and filtering process. This creates a highly purified, gel-like HA
fluid.
It’s also animal free.

Why EUFLEXXA

How to know if you're
ready for treatment

If any of these sound like you, EUFLEXXA may be able to help.

  • Remedies that used to work
    for me
    (eg, ice packs, exercise,
    etc) don't have
    the same
    effect anymore.

  • I’ve cut back (or stopped)
    participating in daily
    activities I used to enjoy.

  • Over-the-counter pain
    medications like acetaminophen
    don't relieve my pain.

OA=osteoarthritis.

Find out what EUFLEXXA can do for you

#1 prescribed HA is based on rolling 12-month average of IQVIA claims data from unique patients (August 2018-August 2019).

Please see Important Safety Information and Full Prescribing Information

Open
Close

INDICATION

EUFLEXXA (1% sodium hyaluronate) is used to relieve knee pain due to osteoarthritis. It is used for patients who do not get enough relief from simple pain medications such as acetaminophen or from exercise and physical therapy.

EUFLEXXA is only for injection into the knee, performed by a doctor or other qualified healthcare professional.

IMPORTANT SAFETY INFORMATION

  • Do not take this product if you have had any previous allergic reaction to EUFLEXXA or hyaluronan products.
  • You should not have EUFLEXXA injected into the knee if you have a knee joint infection or skin diseases or infections around the injection site.
  • EUFLEXXA has not been tested in pregnant women, women who are nursing or in children less than 18 years of age. After you receive your EUFLEXXA injection you should avoid physical activities for 48 hours such as jogging, tennis, heavy lifting, or standing on your feet for a long time (more than one hour at a time).
  • The most common adverse events related to EUFLEXXA injections were joint pain, back pain, limb pain, muscle pain, and joint swelling.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

You may also contact Ferring Pharmaceuticals Inc. at 1-888-FERRING.

Please see Important Safety Information and Full Prescribing Information

INDICATION

EUFLEXXA (1% sodium hyaluronate) is used to relieve knee pain due to osteoarthritis. It is used for patients who do not get enough relief from simple pain medications such as acetaminophen or from exercise and physical therapy.

EUFLEXXA is only for injection into the knee, performed by a doctor or other qualified healthcare professional.

IMPORTANT SAFETY INFORMATION

  • Do not take this product if you have had any previous allergic reaction to EUFLEXXA or hyaluronan products.
  • You should not have EUFLEXXA injected into the knee if you have a knee joint infection or skin diseases or infections around the injection site.
  • EUFLEXXA has not been tested in pregnant women, women who are nursing or in children less than 18 years of age. After you receive your EUFLEXXA injection you should avoid physical activities for 48 hours such as jogging, tennis, heavy lifting, or standing on your feet for a long time (more than one hour at a time).
  • The most common adverse events related to EUFLEXXA injections were joint pain, back pain, limb pain, muscle pain, and joint swelling.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

You may also contact Ferring Pharmaceuticals Inc. at 1-888-FERRING.